Compare CERS & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CERS | NPCE |
|---|---|---|
| Founded | 1991 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 501.8M | 490.2M |
| IPO Year | 1996 | 2021 |
| Metric | CERS | NPCE |
|---|---|---|
| Price | $2.64 | $14.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $18.33 |
| AVG Volume (30 Days) | ★ 1.3M | 109.0K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.27 | ★ 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | $51,326,000.00 | ★ $99,986,000.00 |
| Revenue This Year | $19.95 | $0.90 |
| Revenue Next Year | $8.84 | $24.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 30.68 | 25.13 |
| 52 Week Low | $1.38 | $9.22 |
| 52 Week High | $3.47 | $19.60 |
| Indicator | CERS | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 51.36 | 49.93 |
| Support Level | $2.37 | $13.76 |
| Resistance Level | $2.68 | $14.72 |
| Average True Range (ATR) | 0.09 | 0.51 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 81.25 | 38.22 |
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.